Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors

Author： Thomas Elizabeth A.

Publisher： MDPI

E-ISSN： 1424-8247|7|6|634-661

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.7, Iss.6, 2014-05, pp. : 634-661

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Thoroughly Validated Virtual Screening Strategy for Discovery of Novel HDAC3 Inhibitors

By Hu Huabin Xia Jie Wang Dongmei Wang Xiang Simon Wu Song

International Journal of Molecular Sciences, Vol. 18, Iss. 1, 2017-01 ,pp. : 137-137

MDPI

Access to resources Recommend Favorite

miR-365 Ameliorates Dexamethasone-Induced Suppression of Osteogenesis in MC3T3-E1 Cells by Targeting HDAC4

By Xu Daohua Gao Yun Hu Nan Wu Longhuo Chen Qian

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-05 ,pp. : 977-977

MDPI

Access to resources Recommend Favorite

CIK Cells and HDAC Inhibitors in Multiple Myeloma

By Stephan David Weiher Hans Schmidt-Wolf Ingo G.H.

International Journal of Molecular Sciences, Vol. 18, Iss. 5, 2017-04 ,pp. : 945-945

MDPI

Access to resources Recommend Favorite

HDAC6 and Ovarian Cancer

By Haakenson Joshua Zhang Xiaohong

International Journal of Molecular Sciences, Vol. 14, Iss. 5, 2013-05 ,pp. : 9514-9535

MDPI

Access to resources Recommend Favorite

HDAC Inhibitors and RECK Modulate Endoplasmic Reticulum Stress in Tumor Cells

By Chen Yun Tsai Ya-Hui Tseng Sheng-Hong

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-01 ,pp. : 258-258

MDPI

Access to resources Recommend Favorite